Pinned Tweet
Hoy me recibí de hematóloga gracias a todos los que me acompañaron y apoyaron en este proceso !! Sin duda este logro es compartido 🥹❤️
Denisse🌻 retweeted
GUÍAS ASH 2026: DIAGNÓSTICO DE DEFICIENCIA DE HIERRO 🧵
➡️Blood Advances
📌Adiós a ferritina ≤12-15 ng/mL
✅Nuevos umbrales por población
📍Inflamación: ferritina + TSAT
📍Algoritmo diagnóstico
doi: 10.1182/bloodadvances.2025015950
Denisse🌻 retweeted
Immunotherapy for acute leukemia: An updated SITC clinical practice guideline jitc.bmj.com/content/14/9/e0… #AML #ALL #leusm
Denisse🌻 retweeted
Follicular lymphoma 2027 • ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES
onlinelibrary.wiley.com/doi/…
@AjHematology
Denisse🌻 retweeted
Tumor Lysis Syndrome sciencedirect.com/science/ar…
Denisse🌻 retweeted
B-cell precursor acute lymphoblastic leukaemia: origins, classification, and therapeutic advances doi.org/10.1016/j.pharmthera… #leusm
Denisse🌻 retweeted
Early Toxicities of CAR-T Cell Therapy: Mechanisms, Prediction, and Management mdpi.com/4159096 #mdpiijms via @IJMS_MDPI
Denisse🌻 retweeted
Prognosis in marginal zone lymphoma: a comprehensive review haematologica.org/article/vi… #lymsm
Denisse🌻 retweeted
VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy #mpnsm ascopubs.org/doi/abs/10.1200…
Denisse🌻 retweeted
Brentuximab vedotin-containing regimen time toxicity for front-line therapy of advanced-stage classical Hodgkin lymphoma in young adults and adults: Real-life comparison between condensed BrECADD versus traditional Bv + AVD onlinelibrary.wiley.com/doi/… #lymsm
Denisse🌻 retweeted
First-line ibrutinib plus venetoclax for nonblastoid mantle cell lymphoma in patients ≥65 years old or with TP53 mutations ashpublications.org/blood/ar… #lymsm
Denisse🌻 retweeted
Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study ashpublications.org/blood/ar… #leusm
Denisse🌻 retweeted
Maintenance Therapy in Acute Myeloid Leukemia: Current Perspectives and Future Directions mdpi.com/3941900 #mdpicurroncol via @CurrentOncology #leusm
Denisse🌻 retweeted
Hoy hicimos el lanzamiento de la 5ta edición de nuestras Jornadas Integradas de Hematología "Hematología al día" @hcmquintela @fmedoficial
Denisse🌻 retweeted
CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now? mdpi.com/3337380 #mdpicurroncol via @CurrentOncology #leusm
Denisse🌻 retweeted
Novel treatment strategies in acute myeloid leukemia bloodresearch.or.kr/journal/… #leusm
Denisse🌻 retweeted
An Algorithm to manage differenciation syndrome in APL ashpublications.org/blood/ar…
🤖 Made with AI
Denisse🌻 retweeted
How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm? nature.com/articles/s41409-0… #mpnsm
Denisse🌻 retweeted
Acute Promyelocytic Leukemia: Pathophysiology, Diagnosis and Clinical Management mdpi.com/3612044 #mdpihematolrep via @HematologyRepo1 #APL #leusm
Denisse🌻 retweeted
New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification onlinelibrary.wiley.com/doi/… #mpnsm
Denisse🌻 retweeted
The new debate in Hodgkin lymphoma: are we choosing the best treatment—or the best treatment for each patient?. @CarolinaMahuad @WomenInLymphoma authors.elsevier.com/c/1n~HW…




























